TT virus infection in end-stage renal disease (ESRD)

Journal of Nephrology

Volumn 14, Issue 2, 2001, Pages 80-87

  Fabrizi, Fabrizio ^a   Martin, Paul ^b   Lunghi, Giovanna ^a   Locatelli, Francesco ^c  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c A MANZONI HOSPITAL   (Italy)

Author keywords

ESRD; Hemodialysis; Liver disease; TTV

Indexed keywords

BLOOD TRANSFUSION; CLINICAL FEATURE; DIALYSIS; DIFFUSION; DISEASE ASSOCIATION; HEPATITIS C; HEPATITIS VIRUS; HOSPITAL INFECTION; HUMAN; KIDNEY FAILURE; MAINTENANCE THERAPY; PREVALENCE; REVIEW; TORQUE TENO VIRUS; VIRUS INFECTION; VIRUS TRANSMISSION;

COMORBIDITY; FEMALE; HEPATITIS, VIRAL, HUMAN; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PREVALENCE; PROGNOSIS; RENAL DIALYSIS; RISK FACTORS; TORQUE TENO VIRUS;

EID: 0035036075     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Tokars JI, Miller ER, Alter MJ, Arduino MJ. National surveillance of dialysis-associated diseases in the United States, 1995. ASAIO J 1998; 44: 98-107.
2. Limido A, Conte F, Malberti F, Spotti D, Marcelli D, Locatelli F. Misure di profilassi delle infezioni da virus B e C in Lombardia: Dati del Registro Lombardo Dialisi e Trapianto (RLDT). Giorn It Nefrol 2000; 17: 266 (abstract).
3. Djordjevic V, Stojanovic K, Stojanovic M, Stefanovic V. Prevention of nosocomial transmission of hepatitis C infection in a hemodialysis unit. A prospective study. Int J Artif Organs 2000; 23: 181-8.
4. Todorov V, Boneva R, Ilieva P, Doichinova T, Donchev M. High prevalence of hepatitis C virus infection in one dialysis center in Bulgaria. Nephron 1998, 79: 222-3 (letter).
5. Sayner AA, Zeytinoglu A, Ozkahya M. HCV infection in haemodialysis and CAPD patients. Nephrol Dial Transplant 1998; 14: 256-7 (letter).
6. Covic A, Iancu L, Apetrei C, Scripcaru D, Volovat C, Mititiuc I, Covic M. Hepatitis virus infection in haemodialysis patients from Moldavia. Nephrol Dial Transplant 1999; 14: 40-5.
7. Fabrizi F, Martin P. GBV-C/HGV infection in ESRD. J Nephrol 1999; 12: 131-9.
8. Bonis PAL. TT virus. J Am Soc Nephrol 1999; 10: 1828-32.
9. Nishizawa T, Okamoto H, Konishi K, Yoshizawa H, Miyakawa Y, Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997; 241: 92-7.
10. Okamoto H, Nishizawa T, Kato N, Ukita M, Ikeda H, Izuka H, Miyakawa Y, Mayumi M. Molecular cloning and characterization of a novel DNA virus (TTV) associated with posttransfusion hepatitis of unknown etiology. Hepatol Res 1998; 10: 1-16.
11. Takahashi K, Ohta Y, Mishiro S. Partial 2.4-kb sequences of TT virus (TTV) genome from eight Japanese isolates: diagnostic and phylogenetic implications. Hepatol Res 1998; 12: 111-20.
12. Mushawar IK, Erker JC, Muerhoff AS, Leary TP, Simons JN, Birkenmeyer LG, Chalmers ML, Pilot-Matias TJ, Desai SM. Molecular and biophysical characterization of TT virus: evidence for a new virus family infecting humans. Proc Natl Acad Sci USA 1999; 96: 3177-82.
13. Pereira HG, Fialho AM, Flewett TH, Teixeira JM, Andrade ZP. Novel viruses in human faeces. Lancet 1988; 2: 103-4.
14. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK. Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1: 564-9.
15. Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H, Koonin E, Gallagher M, Alter M, Hadziyannis S, Karayannis P, Fung K, Nakatsuji Y, Shih JWK, Young L, Piatak M, Hoover C, Fernandez J, Chen S, Zou JC, Morris T, Hyams KC, Ismay S, Lifson JD, Hess G, Foung SKH, Thomas H, Bradley D, Margolis H, Kim JP. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-8.
16. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Bruwer JT, Chan SW, Chayama K, Cheng DS, Choo QL, Colombo M, Cuypers HTM, Date T, Dusheiko GM, Esteban JI, Fau O, Hadziyannis SJ, Han J, Hatzakis A, Holmes EC, Hoka H, Houghton M, Irvine B, Kohara M, Kolberg JA, Kuo G, Lau YJN, Lelie PN, Maertens G, McOmish F, Miyamura T, Mizokami M, Nomoto A, Prince AM, Reesink HW, Rice C, Roggendorf M, Schalm SW, Shikata T, Shimotohno K, Stuyver L, Trepo C, Weiner A, Yap PL, Urdea MS. A proposed system for nomenclature of hepatitis C viral genotypes. Hepatology 1994; 19: 132M.
17. Prescott LE, Simmonds P. Global distribution of transfusion-transmitted virus. N Engl J Med 1998; 11: 776-7 (letter).
18. Charlton M, Adjei P, Poterucha J, Zein N, Therneau T, Krom R, Wiesner R. TT virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis. Hepatology 1998; 28: 839-42.
19. Niel C, De Oliveira JM, Ross RS, Gomes SA, Roggendorf MN, Viazov S. High prevalence of TT virus infection in Brazilian blood donors. J Med Virol 1999; 57: 259-63.
20. Kao JH, Chen W, Hsiang SC, Chen PJ, Lai MY, Chen DS. Prevalence and implication of TT virus infection: minimal role in patients with non-A-E hepatitis in Taiwan. J Med Virol 1999; 59: 307-12.
21. Gad A, Tanaka E, Orii K, Kafumi T, Serwah AEH, El-Sherif A, Nooman Z, Kiyosara K. Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt. J Med Virol 2000; 60: 177-81.
22. Berg T, Schreier E, Heuft HG, Hohne M, Becgsteing WO, Leder K, Hopf U, Neuhaus P, Wiedemann B. Occurrence of a novel DNA virus (TTV) infection in patients with liver diseases and its frequency in blood donors. J Med Virol 1999; 59: 117-21.
23. Tanaka Y, Mizokami M, Onto E, Nakano T, Kato T, Ding X, Ohno T, Ueda R, Sonoda S, Taijma K, Miura T, Hayami M. A new genotype of TT virus (TTV) infection among Colombian native Indians. J Med Virol 1999; 57: 264-8.
24. Davidson F, Mac Donald D, Mokili JL, Prescott LE, Graham S, Simmonds P. Early acquisition of TT virus (TTV) in an area endemic for TTV infection. J Infect Dis 1999; 179: 1070-6.
25. Simmonds P, Davidson F, Lycett C, Prescott LE, MacDonald DM, Ellender J, Yap PL, Ludlam CA, Haydon GH, Gillon J, Jarvis LM. Detection of a novel DNA virus (TTV) in blood donors and blood products. Lancet 1998; 352: 191-5.
26. Okamoto H, Akahane Y, Ukita M, Fukuda M, Tsuda F, Miyakawa Y, Mayumi M. Fecal excretion of a nonenveloped DNA virus (TTV) associated with posttransfusion non-A-G hepatitis. J Med Virol 1998; 56: 128-32.
27. Luo KL, Liang W, He H, Yang S, Wang Y, Xiao H, Liu D, Zhang L. Experimental infection of nonenveloped DNA virus (TTV) in Rhesus Monkey. J Med Virol 2000; 61: 159-64.
28. Pattison JR. Parvoviruses: Medical and biological aspects. In: Fields BN, Knipe DM, Chanock RM, Hirsh MS, Melnick JL, Monath TP, Roizman B, eds. Fields Virology, 2nd ed. New York: Raven Press, 1990: 1765-84.
29. Huang YH, Wu JC, Lin CC, Sheng WY, Lee PC, Wang YJ, Chang FY, Lee SD. Prevalence and risk factors analysis of TTV infection in prostitutes. J Med Virol 2000; 60: 393-5.
30. Desai SM, Muerhoff S, Leary TP, Erker JC, Simons JN, Chalmers ML, Birkenmeyer LG, Pilot-Matias TJ, Mushahwar IK. Prevalence of TT virus infection in US blood donors and populations at risk for acquiring parenterally transmitted viruses. J Infect Dis 1999; 179: 1242-4.
31. Sugiyama K, Goto K, Ando T, Mizutani F, Terabe K, Kawabe Y, Yokoyama T, Wada Y. Prevalence of TTV DNA among children with a history of transfusion or liver disease. J Med Virol 2000; 60: 172-6.
32. Zuckerman AJ. The acronym TTV. Lancet 1999; 353: 932.
33. Takahashi K, Hoshino H, Ohta Y, Yoshida N, Mishiro S. Very high prevalence of TT virus (TTV) infection in general population of Japan revealed by a new set of PCR primers. Hepatol Res 1998; 12: 233-9.
34. Utsunomiya S, Yoshioka K, Wakita T, Seno H, Takagi K, Ishigami M, Yano M, Watanabe K, Kobayashi M, Watanabe K, Kishimoto H, Kakumu S. TT virus infection in hemodialysis patients. Am J Gastroenterol 1999; 94: 3567-70.
35. Forns X, Hegerich P, Darnell A, Emerson SU, Purcell RH, Bukh J. High prevalence of TT virus (TTV) infection in patients on maintenance hemodialysis: frequent mixed infections with different genotypes and lack of evidence of associated liver disease. J Med Virol 1999; 59: 313-7.
36. Yuki N, Kato M, Masuzawa M, Ishida H, Inoue T, Tahata T, Matsushita Y, Kishimoto H, Sasaki Y, Hayashi N, Hori M. Clinical implications of coinfection with a novel DNA virus (TTV) in hepatitis C virus carriers on maintenance hemodialysis. J Med Virol 1999; 59: 431-6.
37. Gallian P, Berland Y, Olmer M, Raccah D, De Micco P, Biagini P, Simon S, Bouchouareb D, Mourey C, Roubicek C, Tounssi M, Cantaloube JF, Dussol B, De Lamballerie X. TT virus infection in French hemodialysis patients: study of prevalence and risk factors. J Clin Microbiol 1999; 37: 2358-542.
38. Ikeuchi T, Okuda K, Yokosuka O, Kanda T, Kobayashi S, Murata M, Hayashi H, Yokozeki K, Ohtake Y, Kashima T, Irie Y. Superinfection of TT virus and hepatitis C among chronic haemodialysis patients. J Gastroenterol Hepatol 1999; 14: 796-800.
39. Finazzi S, Como G, Sampietro M, Martinez di Montemuros F, Tavazzi D, Lunghi G, Orlandi A, Fiorelli G, Ponticelli C. Infezione da TT virus in pazienti emodializzati. Giorn It Nefrol 2000; 17: 500-4.
40. Barril G, Lopez-Alcorocho JM, Bajo A, Ortiz-Movilla N, Sanchez-Tomero JA, Bartolome J, Selgas R, Carreno V. Prevalence of TT virus in serum and peripheral mononuclear cells from a CAPD population. Pent Dial Int 2000; 20: 65-8.
41. Michitaka K, Koriike N, Matsubara H, Kojima N, Onji M, Toshino A, Oka A, Ohoka H, Yokoyama M. TT virus infection among renal transplant recipients. Hepatology 1998; 28: 2278 (abstract).
42. Liaw YF. Role of hepatitis C virus in dual and triple hepatitis virus infection. Hepatology 1995; 22: 1101-8.
43. Ozylkan E, Ebas T, Simsek H, Telatar F, Kayhan B, Telatar H. Increased prevalence of hepatitis C virus antibodies in patients with diabetes mellitus. J Intern Med 1994; 235: 283-4.
44. Simo R, Hernandez C, Genesca J, Jardi R, Mesa J. High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996; 19: 998-1000.
45. Soma J, Saito T, Taguma Y, Chiba S, Sato H, Sugimura K, Ogawa S, Ito S. High prevalence and adverse effect of hepatitis C virus infection in type II diabetic-related nephropathy. J Am Soc Nephrol 2000; 11: 690-9.
46. Fabrizi F, Marcelli D, Guarnori I, Bacchini G, Erba GF, Locatelli F. Anti-HCV antibodies in chronic renal failure patients on conservative therapy: prevalence, risk factors and relationship with liver disease. Nephrol Dial Transplant 1994; 9: 7804.
47. Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Carnot F, Berthelot P, Brechot C. Hepatitis C virus RNA in anti-HCV positive hemodialysed patients: significance and therapeutic implications. Kidney Int 1993; 44: 1097-100.
48. Shade RO, Blundell MC, Cotmore SF. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986; 58: 921-36.